Cancer BiologybioRxiv
Tribbles 2 confers enzalutamide resistance in prostate cancer by promoting lineage plasticity.
J. Monga, I. Adrianto, C. Rogers…·J. Ghosh
This study identifies Tribbles 2 as a driver of enzalutamide resistance in prostate cancer by promoting lineage plasticity and neuroendocrine differentiation.
DOI 10.1016/j.jbc.2021.101556